CN Stock MarketDetailed Quotes

688506 Sichuan Biokin Pharmaceutical

Watchlist

211.00
-6.75-3.10%

Market Closed Mar 7 15:00 CST

84.61BMarket Cap22.27P/E (TTM)

Sichuan Biokin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sichuan Biokin Pharmaceutical FY2024 Estimates Date

Currency：CNYMar 29, 2025

	Estimate	YoY
Revenue	6.05B	+977.00%
EPS	9.26	+574.73%

Analyst Rating

Strong Buy

Mar 9, 2025

Sichuan Biokin Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2026/FY	-- / 2.751B	--
--	2025/FY	-- / 2.250B	--
Mar 29, 2025	2024/FY	5.823B / 6.051B	--
--	2023/FY	561.871M / 562.000M	--

DatePeriodRevenue/EstimateEarnings Call

--2026/FY-- / 2.751B--

--2025/FY-- / 2.250B--

Mar 29, 20252024/FY5.823B / 6.051B--

--2023/FY561.871M / 562.000M--

--------

Unlock Free Earnings Estimates

Open Account

Sichuan Biokin Pharmaceutical Earnings Reports

Baili Tianheng: Sichuan Baili Tianheng Pharmaceutical Co., Ltd. 2024 Annual Results Express Announcement

Feb 27 11:00 ET

Sichuan Baili Tianheng Pharmaceutical Co., Ltd. 2024 Annual Results Express Announcement